Navigation Links
Genome Area Linked to Rheumatoid Arthritis
Date:9/18/2007

DNA is involved in inflammation, immune response, scientists say

TUESDAY, Sept. 18 (HealthDay News) -- A specific region of the human genome appears to be associated with rheumatoid arthritis, European researchers say.

A team from the Karolinska Institute, Stockholm, and elsewhere, conducted genetic analyses of hundreds of rheumatoid arthritis patients.

They found a consistent association between the disease and one region of the genome. This region, on chromosome 9, includes two genes called complement component 5 (C5) and TNF receptor-associated factor 1 (TRAF1).

TRAF1 is involved in inflammatory response, and C5 plays a role in the complement system, involved in defending the body against foreign molecules, the researchers said.

The chromosome region in which these genes are located may be involved in the binding of a protein that modifies the transcription of genes. The researchers also found that one of the alternative markers in this region is associated with more aggressive rheumatoid arthritis.

The findings add to a growing body of evidence that this region is associated with rheumatoid arthritis, which is caused by an abnormal immune response to various tissues within the body. The condition affects about one percent of people in developed countries.

The findings are published this week in the journal PLoS Medicine.

More information

The American Academy of Family Physicians has more about rheumatoid arthritis.



-- Robert Preidt



SOURCE: Public Library of Science, news release, Sept. 17, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. Controversial deal on public access of the human genome map
3. Innovative yeast genome may handle Cancer Clues
4. Primates reveal a new dimension to human genome
5. Human Diseases May Have Clue In Human-Chimp Genome Difference
6. Race Based Genome Project Launched By Mexico
7. Dog (Mans best friend) Genome Sequenced
8. Decoding the Fungi Genome Will Save Millions of Lives.
9. Yeast Genome Unravels Genes Critical For Maintaining DNA Integrity
10. Novel method conceived, to achieve genome-wide gene silencing.
11. Unraveling the Secrets of MHC in Human Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: